Kevin Koch's Net Worth
$1.22 Million
Who is Kevin Koch?
Kevin Koch has an estimated net worth of $1.22 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., Edgewise Therapeutics, Inc., and ARRAY BIOPHARMA INC.
SEC CIK
Kevin Koch's CIK is 0001185829
Past Insider Trading and Trends
2005 was Kevin Koch's most active year for acquiring shares with 3 total transactions. Kevin Koch's most active month to acquire stocks was the month of July. 2013 was Kevin Koch's most active year for disposing of shares, totalling 3 transactions. Kevin Koch's most active month to dispose stocks was the month of April. 2013 saw Kevin Koch paying a total of $83,572.50 for 142,286 shares, this is the most they've acquired in one year. In 2007 Kevin Koch cashed out on 46,900 shares for a total of $657,700.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
| +100.72% | 7.26K |
$18.91 | -$59,604.32 | 14.48K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
∞
| 7.21K |
$8.90 | -$28,522.39 | 7.21K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARRAY BIOPHARMA INC No price found
President, CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -1.29% | -10.32K |
$6.07 | -$62,660.61 | 786.92K |
Jul 24
| |||
Form 4
| +1.28% | 9.92K |
$4.91 | $8,516.95 | 784.88K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
| +3.02% | 22.72K |
—
|
—
| 774.95K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +7.16% | 50.27K |
—
|
—
| 752.24K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +7.35% | 48.03K |
—
|
—
| 701.97K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +4.62% | 28.86K |
$0.60 | $17,317.80 | 653.93K |
Nov 12
| |||
Form 4
| +5.86% | 34.6K |
—
|
—
| 625.07K |
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
| +6.32% | 35.12K |
$0.24 | $8,252.97 | 590.47K |
Feb 12
| |||
Form 4
| -3.48% | -20.00K |
$14.06 | -$281,100.00 | 555.35K |
Scheduled
|
Feb 5
| ||
Form 4
| -4.47% | -26.90K |
$14.00 | -$376,600.00 | 575.35K |
Jan 19
| |||
Form 4
| -3.21% | -20.00K |
$9.38 | -$187,680.00 | 602.25K |
Scheduled
|
Feb 17
| ||
Form 4
| +0.10% | 796 |
$3.75 | $2,985.00 | 764.54K |
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 4
| +1.22% | 9.2K |
$0.37 | $3,372.96 | 763.74K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1 - Aug 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||